News and events
Find out the latest news and updates about the regulation of therapeutic goods in Australia, as well as events, webinars and consultations with the community.
This page is in Beta testing. We welcome your feedback and suggestions as we look to improve this page.
Industry notices and compliance undertakings
Notifications for sponsors, manufacturers, and advertisers about official decisions and new or updated regulatory requirements, as well as information about recent regulatory compliance and enforcement actions.
-
Regulatory decision notices
Access official regulatory decisions for sponsors, manufacturers and advertisers, including GMP clearances, listing notices, administrative instruments, and updates to regulatory requirements. -
Latest articles
-
Be alert to FluMist indicated age range
We have identified reports of FluMist being administered in error to children under 2 years of age. -
What to know if you've been prescribed medicinal cannabis
Understanding the difference between an approved and unapproved therapeutic good can help you make informed decisions and have meaningful conversations with your healthcare practitioner, especially when considering treatments like medicinal cannabis. -
Do your patients know the risks of unapproved medicinal cannabis products?
Medicinal cannabis prescribing in Australia has increased significantly in recent years. However, many patients are unaware that most medicinal cannabis products are unapproved goods. As a prescriber, you play a critical role in ensuring patients are informed, protected and supported when these products are being considered for their clinical situation.
Latest publications
-
This report summarises the outcomes of the Pharmacovigilance Inspection Program in the 2-year period. The deficiencies identified are presented along with case studies of critical deficiencies from this reporting period, to support medicine sponsors in the continual improvement of their pharmacovigilance systems.
-
This web publication constitutes a notice for the purposes of regulation 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).
-
Communique from the 12th meeting of the Women's Health Products Working Group, 31 March 2026.
Latest consultations
-
Have your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS), Advisory Committee on Chemicals Scheduling (ACCS), and the joint meeting of the ACMS and ACCS.
-
We are seeking feedback on proposed changes to improve the regulation of therapeutic sunscreens in Australia.
-
We are seeking feedback on proposed changes to Australian medicine labelling rules. The consultation end date has been extended to 23 March 2026.